by Heidi Hagen | June 19, 2019
In cell therapy and gene therapy, in-process and final product labeling matters more to patient safety than ever before -- and it’s also more complex. We’ve been working with other industry leaders on new and updated standards for cell and gene…
by Heidi Hagen | June 12, 2019
At the recent ISCT 2019 annual meeting, Heidi Hagen from Vineti was invited to speak on the topic of cell therapy data management. Here are a few highlights from her presentation.
by Marc Puich | June 4, 2019
Success depends on defining and communicating broadly all facets of the therapy’s “real world” process requirements.
by Vineti | May 30, 2019
In personalized therapies -- cell therapies, gene therapies, and neoantigen therapies -- a patient is not just the recipient of a drug product. The patient is the product.
by Amy DuRoss | May 22, 2019
One week to go! In the next seven days, those of us working in cell and gene therapy have a great chance to give input that will help our industry grow. See some areas of focus, with screenshots, in this post.